Our previous studies show that this aggressive population has increased self-renewal properties (contributing to tumor recurrence), increased invasiveness, and ability to evade adverse chemotherapeutic assault on the tumor and is represented by the expression of CD133 on their surface5,6. This evidence concerns the gene PROM1 and neoplasm.